US Stock MarketDetailed Quotes

KRYS Krystal Biotech

Watchlist
  • 187.150
  • -1.460-0.77%
Close Mar 21 16:00 ET
  • 187.150
  • 0.0000.00%
Post 20:01 ET
5.39BMarket Cap62.38P/E (TTM)

Krystal Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
238.98%123.42M
830.68%52.84M
377.29%58.86M
87.81%-4.17M
160.74%15.89M
11.70%-88.8M
67.61%-7.23M
-7.81%-21.23M
20.60%-34.19M
-68.82%-26.16M
Net income from continuing operations
715.58%89.16M
423.23%45.48M
-66.34%27.18M
146.88%15.57M
102.06%932K
107.81%10.93M
127.12%8.69M
370.51%80.75M
-18.15%-33.21M
9.34%-45.3M
Operating gains losses
94.23%-6.07M
-36.15%-1.64M
98.46%-1.57M
-4.11%-1.65M
-49.94%-1.21M
-18,337.19%-105.09M
-103.72%-1.21M
---101.5M
---1.58M
---809K
Depreciation and amortization
13.58%6.71M
-11.50%1.56M
12.01%1.53M
36.74%2.02M
22.73%1.61M
74.62%5.91M
319.33%1.76M
40.00%1.37M
51.43%1.48M
29.16%1.31M
Other non cash items
200.46%652K
-124.83%-73K
600.79%636K
567.35%327K
-23,900.00%-238K
538.24%217K
13.95%294K
-118.97%-127K
258.06%49K
100.74%1K
Change In working capital
62.47%-14.46M
78.25%-5.66M
291.78%18.2M
-181.74%-33.29M
-28.45%6.3M
-1,549.83%-38.52M
-4,356.16%-26.02M
-5,885.37%-9.49M
50.94%-11.82M
-67.58%8.81M
-Change in receivables
-49.16%-62.71M
77.24%-7.45M
163.75%5.94M
---56.77M
---4.43M
---42.04M
---32.72M
---9.32M
--0
--0
-Change in inventory
-166.08%-11.91M
-1,225.41%-6.52M
-19.53%-3.68M
158.50%530K
---2.24M
---4.48M
---492K
---3.08M
---906K
--0
-Change in prepaid assets
-452.67%-8.91M
-446.43%-6.27M
-156.22%-104K
-333.65%-2.27M
-109.52%-264K
-162.11%-1.61M
30.26%-1.15M
1.09%185K
-1,967.86%-523K
-115.37%-126K
-Change in payables and accrued expense
556.31%68.48M
66.13%14.15M
419.03%16.1M
340.64%24.86M
46.29%13.38M
166.24%10.43M
598.77%8.52M
1,450.50%3.1M
56.89%-10.33M
-65.44%9.14M
-Change in other current assets
----
----
88.61%-18K
-114.74%-23K
213.04%52K
----
----
-243.48%-158K
2,500.00%156K
-611.11%-46K
-Change in other current liabilities
170.69%586K
295.58%442K
82.96%-38K
277.21%381K
-20.61%-199K
-28.13%-829K
-20.21%-226K
-28.90%-223K
-34.38%-215K
-30.95%-165K
Cash from discontinued investing activities
Operating cash flow
238.98%123.42M
830.68%52.84M
377.29%58.86M
87.81%-4.17M
160.74%15.89M
11.70%-88.8M
67.61%-7.23M
-7.81%-21.23M
20.60%-34.19M
-68.82%-26.16M
Investing cash flow
Cash flow from continuing investing activities
-297.78%-163.44M
-724.59%-83.78M
-132.63%-34.33M
-21.28%-19.35M
-829.16%-25.98M
172.44%82.64M
-95.08%-10.16M
813.50%105.19M
58.25%-15.96M
106.37%3.56M
Net PPE purchase and sale
64.08%-4.24M
56.63%-801K
41.27%-1.05M
59.46%-1.13M
76.58%-1.26M
77.73%-11.8M
64.60%-1.85M
87.33%-1.78M
83.11%-2.79M
68.70%-5.38M
Net investment purchase and sale
-2,761.78%-159.2M
-898.16%-82.98M
-577.30%-33.28M
-38.39%-18.22M
-376.39%-24.72M
90.90%-5.56M
-92,466.67%-8.31M
1,114.99%6.97M
39.35%-13.17M
123.10%8.94M
Net other investing changes
----
----
----
----
----
--100M
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
-297.78%-163.44M
-724.59%-83.78M
-132.63%-34.33M
-21.28%-19.35M
-829.16%-25.98M
172.44%82.64M
-95.08%-10.16M
813.50%105.19M
58.25%-15.96M
106.37%3.56M
Financing cash flow
Cash flow from continuing financing activities
-86.68%27.01M
-7.29%2.43M
-74.87%3.37M
-94.26%10.64M
617.98%10.58M
473.60%202.75M
-14.66%2.62M
531.51%13.39M
503.48%185.27M
371.96%1.47M
Net common stock issuance
--0
--0
--0
----
----
451.01%159.73M
100.25%10K
-105.75%-122K
----
----
Proceeds from stock option exercised by employees
-25.98%32.4M
-6.94%2.43M
-75.09%3.37M
-58.17%10.64M
618.35%15.97M
524.61%43.77M
--2.61M
--13.51M
--25.43M
--2.22M
Net other financing activities
-619.09%-5.39M
--0
--0
--0
-619.09%-5.39M
-15.41%-749K
--0
--0
--0
-15.41%-749K
Cash from discontinued financing activities
Financing cash flow
-86.68%27.01M
-7.29%2.43M
-74.87%3.37M
-94.26%10.64M
617.98%10.58M
473.60%202.75M
-14.66%2.62M
531.51%13.39M
503.48%185.27M
371.96%1.47M
Net cash flow
Beginning cash position
121.33%358.33M
0.19%373.97M
25.34%345.79M
155.08%359.01M
121.33%358.33M
-52.56%161.9M
100.23%373.24M
26.13%275.88M
-47.74%140.75M
-52.56%161.9M
Current changes in cash
-106.62%-13.01M
-92.97%-28.51M
-71.35%27.89M
-109.53%-12.88M
102.32%491K
209.64%196.58M
39.62%-14.77M
401.30%97.35M
367.13%135.12M
70.64%-21.12M
Effect of exchange rate changes
-193.59%-458K
-324.29%-594K
2,283.33%286K
-4,312.50%-337K
619.44%187K
-280.49%-156K
-241.46%-140K
--12K
--8K
---36K
End cash Position
-3.76%344.87M
-3.76%344.87M
0.19%373.97M
25.34%345.79M
155.08%359.01M
121.33%358.33M
121.33%358.33M
100.23%373.24M
26.13%275.88M
-47.74%140.75M
Free cash flow
218.47%119.18M
673.21%52.04M
351.28%57.81M
85.67%-5.3M
146.38%14.63M
34.48%-100.6M
67.04%-9.08M
31.82%-23.01M
37.93%-36.98M
3.51%-31.54M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 238.98%123.42M830.68%52.84M377.29%58.86M87.81%-4.17M160.74%15.89M11.70%-88.8M67.61%-7.23M-7.81%-21.23M20.60%-34.19M-68.82%-26.16M
Net income from continuing operations 715.58%89.16M423.23%45.48M-66.34%27.18M146.88%15.57M102.06%932K107.81%10.93M127.12%8.69M370.51%80.75M-18.15%-33.21M9.34%-45.3M
Operating gains losses 94.23%-6.07M-36.15%-1.64M98.46%-1.57M-4.11%-1.65M-49.94%-1.21M-18,337.19%-105.09M-103.72%-1.21M---101.5M---1.58M---809K
Depreciation and amortization 13.58%6.71M-11.50%1.56M12.01%1.53M36.74%2.02M22.73%1.61M74.62%5.91M319.33%1.76M40.00%1.37M51.43%1.48M29.16%1.31M
Other non cash items 200.46%652K-124.83%-73K600.79%636K567.35%327K-23,900.00%-238K538.24%217K13.95%294K-118.97%-127K258.06%49K100.74%1K
Change In working capital 62.47%-14.46M78.25%-5.66M291.78%18.2M-181.74%-33.29M-28.45%6.3M-1,549.83%-38.52M-4,356.16%-26.02M-5,885.37%-9.49M50.94%-11.82M-67.58%8.81M
-Change in receivables -49.16%-62.71M77.24%-7.45M163.75%5.94M---56.77M---4.43M---42.04M---32.72M---9.32M--0--0
-Change in inventory -166.08%-11.91M-1,225.41%-6.52M-19.53%-3.68M158.50%530K---2.24M---4.48M---492K---3.08M---906K--0
-Change in prepaid assets -452.67%-8.91M-446.43%-6.27M-156.22%-104K-333.65%-2.27M-109.52%-264K-162.11%-1.61M30.26%-1.15M1.09%185K-1,967.86%-523K-115.37%-126K
-Change in payables and accrued expense 556.31%68.48M66.13%14.15M419.03%16.1M340.64%24.86M46.29%13.38M166.24%10.43M598.77%8.52M1,450.50%3.1M56.89%-10.33M-65.44%9.14M
-Change in other current assets --------88.61%-18K-114.74%-23K213.04%52K---------243.48%-158K2,500.00%156K-611.11%-46K
-Change in other current liabilities 170.69%586K295.58%442K82.96%-38K277.21%381K-20.61%-199K-28.13%-829K-20.21%-226K-28.90%-223K-34.38%-215K-30.95%-165K
Cash from discontinued investing activities
Operating cash flow 238.98%123.42M830.68%52.84M377.29%58.86M87.81%-4.17M160.74%15.89M11.70%-88.8M67.61%-7.23M-7.81%-21.23M20.60%-34.19M-68.82%-26.16M
Investing cash flow
Cash flow from continuing investing activities -297.78%-163.44M-724.59%-83.78M-132.63%-34.33M-21.28%-19.35M-829.16%-25.98M172.44%82.64M-95.08%-10.16M813.50%105.19M58.25%-15.96M106.37%3.56M
Net PPE purchase and sale 64.08%-4.24M56.63%-801K41.27%-1.05M59.46%-1.13M76.58%-1.26M77.73%-11.8M64.60%-1.85M87.33%-1.78M83.11%-2.79M68.70%-5.38M
Net investment purchase and sale -2,761.78%-159.2M-898.16%-82.98M-577.30%-33.28M-38.39%-18.22M-376.39%-24.72M90.90%-5.56M-92,466.67%-8.31M1,114.99%6.97M39.35%-13.17M123.10%8.94M
Net other investing changes ----------------------100M--0------------
Cash from discontinued investing activities
Investing cash flow -297.78%-163.44M-724.59%-83.78M-132.63%-34.33M-21.28%-19.35M-829.16%-25.98M172.44%82.64M-95.08%-10.16M813.50%105.19M58.25%-15.96M106.37%3.56M
Financing cash flow
Cash flow from continuing financing activities -86.68%27.01M-7.29%2.43M-74.87%3.37M-94.26%10.64M617.98%10.58M473.60%202.75M-14.66%2.62M531.51%13.39M503.48%185.27M371.96%1.47M
Net common stock issuance --0--0--0--------451.01%159.73M100.25%10K-105.75%-122K--------
Proceeds from stock option exercised by employees -25.98%32.4M-6.94%2.43M-75.09%3.37M-58.17%10.64M618.35%15.97M524.61%43.77M--2.61M--13.51M--25.43M--2.22M
Net other financing activities -619.09%-5.39M--0--0--0-619.09%-5.39M-15.41%-749K--0--0--0-15.41%-749K
Cash from discontinued financing activities
Financing cash flow -86.68%27.01M-7.29%2.43M-74.87%3.37M-94.26%10.64M617.98%10.58M473.60%202.75M-14.66%2.62M531.51%13.39M503.48%185.27M371.96%1.47M
Net cash flow
Beginning cash position 121.33%358.33M0.19%373.97M25.34%345.79M155.08%359.01M121.33%358.33M-52.56%161.9M100.23%373.24M26.13%275.88M-47.74%140.75M-52.56%161.9M
Current changes in cash -106.62%-13.01M-92.97%-28.51M-71.35%27.89M-109.53%-12.88M102.32%491K209.64%196.58M39.62%-14.77M401.30%97.35M367.13%135.12M70.64%-21.12M
Effect of exchange rate changes -193.59%-458K-324.29%-594K2,283.33%286K-4,312.50%-337K619.44%187K-280.49%-156K-241.46%-140K--12K--8K---36K
End cash Position -3.76%344.87M-3.76%344.87M0.19%373.97M25.34%345.79M155.08%359.01M121.33%358.33M121.33%358.33M100.23%373.24M26.13%275.88M-47.74%140.75M
Free cash flow 218.47%119.18M673.21%52.04M351.28%57.81M85.67%-5.3M146.38%14.63M34.48%-100.6M67.04%-9.08M31.82%-23.01M37.93%-36.98M3.51%-31.54M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
+14.85%
New Fortress Energy
NFE
+7.92%
Cars.com
CARS
+2.11%
Halozyme Therapeutics
HALO
+1.31%
Collegium Pharmaceutical
COLL
+0.40%

Unlock the Full List